Engineering Next-Generation Claudin 6 T-Cell Engagers for Enhanced Specificity & Efficacy
Time: 1:45 pm
day: Conference Day 1
Details:
- Navigating the challenges and strategies in developing Claudin 6 T-Cell engagers with high selectivity, minimizing off-target effects on normal tissues
- Exploring the 2+1 format for Claudin 6 T-Cell engagers, designed to enhance tumor selectivity and reduce toxicity
- Reviewing preclinical data demonstrating the potential advantages of Claudin 6 T-Cell engagers in treating germ cell cancers, focusing on efficacy and safety outcomes
